Portal de Periódicos da CAPES

Enhanced radiosensitization and chemosensitization in NF‐κB‐suppressed human oral cancer cells via the inhibition of γ‐irradiation‐ and 5‐FU‐induced production of IL‐6 and IL‐8

2004; Wiley; Volume: 108; Issue: 6 Linguagem: Inglês

10.1002/ijc.11640

1097-0215

Tetsuya Tamatani, Masayuki Azuma, Yuki Ashida, Katsumi Motegi, Rina Takashima, Koji Harada, Shinichi Kawaguchi, Mitsunobu Sato,

interferon and immune responses

Abstract We examined the mechanisms underlying the enhancement of radiosensitivity and chemosensitivity to γ‐irradiation (IR) and 5‐Fluorouracil (5‐FU) in human oral carcinoma cells (B88) in which NF‐κB activity was constitutively suppressed. Three super‐repressor form of IκBα cDNA‐transfected cell (B88mI) clones and 1 empty vector‐transfected cell clone (B88neo) have been established. We found that the tumor‐forming ability in nude mice of B88mI clones was significantly lower than that of B88 or B88neo. This suppressed ability in tumorigenicity was attributed to the down‐regulation of the expression of interleukin (IL)‐1α, IL‐6, IL‐8, vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)‐9 in B88mI cell clones as compared to that in B88 or B88neo. IR and 5‐FU induced a much greater degree of apoptosis, as evidenced by flow cytometry analysis and annexin V staining, in B88mI cell clones than in B88 or B88neo. When tumor‐bearing nude mice were treated with IR or 5‐FU, the suppression of tumor growth was significantly augmented in B88mI cell clones as compared to that in B88 or B88neo. ELISA analysis indicated that although a remarkable increase in production of IL‐6 and IL‐8 was observed in B88 and B88neo after in vitro exposure to IR or treatment with 5‐FU, radiotherapy and chemotherapy‐induced production of these cytokines was significantly suppressed in B88mI cell clones. These findings suggest that production of angiogenic factors and growth factors in response to radiotherapy and chemotherapy is a principal mechanism of inducible radioresistance and chemoresistance in human oral cancers, and establish the inhibition of NF‐κB as a rational approach to improve conventional radiotherapy and chemotherapy outcomes. © 2003 Wiley‐Liss, Inc.